Biosimilar Medicines Reading List | Medicines for Europe

From disruption to care for cancer patients 5 September 2022 Biosimilar medicines are biologic medicines that can be used safely…
Market review Biosimilar medicines policy 2023 - Policy… 27 September 2023 The Biosimilar Market Access Committee (Biosimilar medicines Group, a Medicines…
EMA/HMA share definitive EU-wide position on biosimilar… 19 September 2022 The Biosimilar medicines group, a Medicines for Europe sector group,…
Billions more euros to re-invest in better healthcare thanks… 13 December 2022 Biosimilar medicines deliver access for patients suffering from serious and…